These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 15045522)
41. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Schrading S; Kuhl CK Radiology; 2008 Jan; 246(1):58-70. PubMed ID: 18096529 [TBL] [Abstract][Full Text] [Related]
42. [Comparison of methods for quantifying contrast enhancement exemplified by dynamic MRI mammography]. Knopp MV; Himmelhan N; Radeleff J; Junkermann H; Hess T; Sinn HP; Brix G Radiologe; 2002 Apr; 42(4):280-90. PubMed ID: 12063736 [TBL] [Abstract][Full Text] [Related]
43. Validity of needle core biopsy in the histological characterisation of mammary lesions. Cipolla C; Fricano S; Vieni S; Amato C; Napoli L; Graceffa G; Latteri S; Latteri MA Breast; 2006 Feb; 15(1):76-80. PubMed ID: 16473738 [TBL] [Abstract][Full Text] [Related]
44. False-negative MR imaging of malignant breast tumors. Boetes C; Strijk SP; Holland R; Barentsz JO; Van Der Sluis RF; Ruijs JH Eur Radiol; 1997; 7(8):1231-4. PubMed ID: 9377507 [TBL] [Abstract][Full Text] [Related]
45. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ; Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520 [TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. Hata T; Takahashi H; Watanabe K; Takahashi M; Taguchi K; Itoh T; Todo S J Am Coll Surg; 2004 Feb; 198(2):190-7. PubMed ID: 14759774 [TBL] [Abstract][Full Text] [Related]
47. MR is/is not a useful diagnostic tool for breast cancer management. Van Goethem M; Verslegers I; Biltjes I; Parizel PM Acta Chir Belg; 2007 Jun; 107(3):267-70. PubMed ID: 17685251 [No Abstract] [Full Text] [Related]
48. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma. Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697 [TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance imaging-guided occult breast lesion localization and simultaneous sentinel lymph node mapping. de Lima Docema MF; Costa PA; de Andrade FE; Bevilacqua JL; Elias S; Cerri GG; Barros AC; Nazario AC World J Surg Oncol; 2014 Oct; 12():320. PubMed ID: 25341393 [TBL] [Abstract][Full Text] [Related]
50. Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Satake H; Shimamoto K; Sawaki A; Niimi R; Ando Y; Ishiguchi T; Ishigaki T; Yamakawa K; Nagasaka T; Funahashi H Eur Radiol; 2000; 10(11):1726-32. PubMed ID: 11097398 [TBL] [Abstract][Full Text] [Related]
51. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast]. Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673 [TBL] [Abstract][Full Text] [Related]
52. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Yeung DK; Yang WT; Tse GM Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004 [TBL] [Abstract][Full Text] [Related]
53. Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ. Proulx F; Correa JA; Ferré R; Omeroglu A; Aldis A; Meterissian S; Mesurolle B Br J Radiol; 2016; 89(1058):20150543. PubMed ID: 26568438 [TBL] [Abstract][Full Text] [Related]
54. Histological assessment of breast lesions identified exclusively by magnetic resonance. O'Connor V; Arena E; Albright J; Brown N; O'Connor R; Chung M; DiNome M; Shamonki J Am Surg; 2014 Oct; 80(10):944-7. PubMed ID: 25264635 [TBL] [Abstract][Full Text] [Related]
55. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging. Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691 [TBL] [Abstract][Full Text] [Related]
56. What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard? Sardanelli F; Bacigalupo L; Carbonaro L; Esseridou A; Giuseppetti GM; Panizza P; Lattanzio V; Del Maschio A Radiol Med; 2008 Apr; 113(3):439-51. PubMed ID: 18414812 [TBL] [Abstract][Full Text] [Related]
57. Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma. Kato F; Omatsu T; Matsumura W; Takahashi M; Hosoda M; Takahashi H; Kubota K; Oyama-Manabe N; Terae S; Shirato H Magn Reson Med Sci; 2011; 10(2):129-32. PubMed ID: 21720115 [TBL] [Abstract][Full Text] [Related]
58. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308 [TBL] [Abstract][Full Text] [Related]